Literature DB >> 18556317

Preventing malaria in travellers.

David G Lalloo1, David R Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18556317      PMCID： PMC2427103          DOI： 10.1136/bmj.a153

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa.

Authors:  Arnaud L Fontanet; Sandrine Houzé; Annick Keundjian; Ricarda Schiemann; Pascal Ralaimazava; Rémy Durand; Olivier Cha; Jean-Pierre Coulaud; Jacques Le Bras; Olivier Bouchaud
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-02       Impact factor: 2.184

2.  Risk assessment and disease prevention in travelers visiting friends and relatives.

Authors:  Sonia Y Angell; Ron H Behrens
Journal:  Infect Dis Clin North Am       Date:  2005-03       Impact factor: 5.982

Review 3.  Effectiveness of antimalarial drugs.

Authors:  J Kevin Baird
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

Review 4.  Malaria: prevention in travellers.

Authors:  Ashley M Croft
Journal:  BMJ Clin Evid       Date:  2007-11-29

5.  Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial.

Authors:  C Ohrt; T L Richie; H Widjaja; G D Shanks; J Fitriadi; D J Fryauff; J Handschin; D Tang; B Sandjaja; E Tjitra; L Hadiarso; G Watt; F S Wignall
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

6.  UK malaria treatment guidelines.

Authors:  David G Lalloo; Delane Shingadia; Geoffrey Pasvol; Peter L Chiodini; Christopher J Whitty; Nicholas J Beeching; David R Hill; David A Warrell; Barbara A Bannister
Journal:  J Infect       Date:  2007-01-09       Impact factor: 6.072

7.  Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy.

Authors:  R McGready; K A Hamilton; J A Simpson; T Cho; C Luxemburger; R Edwards; S Looareesuwan; N J White; F Nosten; S W Lindsay
Journal:  Am J Trop Med Hyg       Date:  2001-10       Impact factor: 2.345

8.  Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.

Authors:  David R Hill; J Kevin Baird; Monica E Parise; Linda S Lewis; Edward T Ryan; Alan J Magill
Journal:  Am J Trop Med Hyg       Date:  2006-09       Impact factor: 2.345

9.  A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.

Authors:  Braden R Hale; Seth Owusu-Agyei; David J Fryauff; Kwadwo A Koram; Martin Adjuik; Abraham R Oduro; W Roy Prescott; J Kevin Baird; Francis Nkrumah; Thomas L Ritchie; Eileen D Franke; Fred N Binka; John Horton; Stephen L Hoffman
Journal:  Clin Infect Dis       Date:  2003-02-14       Impact factor: 9.079

10.  Risk factors for malaria in UK travellers.

Authors:  David A Moore; Alison D Grant; Margaret Armstrong; Richard Stümpfle; Ron H Behrens
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-01       Impact factor: 2.184
View more
  8 in total

1.  Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.

Authors:  Nicholas Fisher; Roslaini Abd Majid; Thomas Antoine; Mohammed Al-Helal; Ashley J Warman; David J Johnson; Alexandre S Lawrenson; Hilary Ranson; Paul M O'Neill; Stephen A Ward; Giancarlo A Biagini
Journal:  J Biol Chem       Date:  2012-01-26       Impact factor: 5.157

Review 2.  Antimalarial pharmacology and therapeutics of atovaquone.

Authors:  Gemma L Nixon; Darren M Moss; Alison E Shone; David G Lalloo; Nicholas Fisher; Paul M O'Neill; Stephen A Ward; Giancarlo A Biagini
Journal:  J Antimicrob Chemother       Date:  2013-01-04       Impact factor: 5.790

3.  [Prevention and diagnosis of imported malaria in primary care: Asturias 2002-2012].

Authors:  Ana Gancedo-García; Lucía Terán-Álvarez; Carmen Toyos-Munárriz; Michal Chudácik; Patricio Suárez-Gil
Journal:  Aten Primaria       Date:  2014-05-03       Impact factor: 1.137

4.  Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers.

Authors:  Sanne-Meike Belderok; Anneke van den Hoek; Will Roeffen; Robert Sauerwein; Gerard J B Sonder
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

5.  Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity.

Authors:  Sanna R Rijpma; Jeroen J M W van den Heuvel; Maarten van der Velden; Robert W Sauerwein; Frans G M Russel; Jan B Koenderink
Journal:  Malar J       Date:  2014-09-13       Impact factor: 2.979

6.  Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum.

Authors:  Richard O Mwaiswelo; William Mawala; Per O Iversen; Mariane de Montalembert; Lucio Luzzatto; Julie Makani
Journal:  Malar J       Date:  2020-04-25       Impact factor: 2.979

Review 7.  Advising the traveller.

Authors:  Joanna Herman; Dipti Patel
Journal:  Medicine (Abingdon)       Date:  2017-12-07

8.  GeoSentinel surveillance of illness in returned travelers, 2007-2011.

Authors:  Karin Leder; Joseph Torresi; Michael D Libman; Jakob P Cramer; Francesco Castelli; Patricia Schlagenhauf; Annelies Wilder-Smith; Mary E Wilson; Jay S Keystone; Eli Schwartz; Elizabeth D Barnett; Frank von Sonnenburg; John S Brownstein; Allen C Cheng; Mark J Sotir; Douglas H Esposito; David O Freedman
Journal:  Ann Intern Med       Date:  2013-03-19       Impact factor: 25.391
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.